Induction of rat gastric damage by the endothelium‐derived peptide, endothelin
Open Access
- 1 December 1988
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 95 (4), 1011-1013
- https://doi.org/10.1111/j.1476-5381.1988.tb11733.x
Abstract
The effect of the endogenous vasoconstrictor peptide, endothelin, on gastric mucosal integrity has been investigated in the rat. Local intra-arterial infusion of endothelin, in picomole doses, dose-dependently induced haemorrhagic and necrotic damage in the gastric mucosa. Such injury was not prevented by atropine, cimetidine, adrenoceptor antagonists, indomethacin, or the 5-lipoxygenase inhibitor BW A4C. These results suggest a potential pro-ulcerogenic role of endothelin in the pathogenesis of gastric damage and ulceration.This publication has 5 references indexed in Scilit:
- Selective inhibition of arachidonate 5‐lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivoBritish Journal of Pharmacology, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Close-arterial administration of the thromboxane mimetic U-46619 induces damage to the rat gastric mucosaProstaglandins, 1988
- Gastric mucosal damage induced by local intra‐arterial administration of Paf in the ratBritish Journal of Pharmacology, 1987
- Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosaNature, 1981